Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CREO.L Stock Summary
Top 10 Correlated ETFs
CREO.L
In the News
CREO.L Financial details
Company Rating
Neutral
Market Cap
133.35M
Income
-34.97M
Revenue
29.34M
Book val./share
0.26
Cash/share
0.1
Dividend
-
Dividend %
-
Employees
279
Optionable
No
Shortable
Yes
Earnings
24 Apr 2024
P/E
-3.13
Forward P/E
-3425
PEG
-0.52
P/S
5.96
P/B
1.71
P/C
342.5
P/FCF
-5.73
Quick Ratio
0.75
Current Ratio
1.93
Debt / Equity
0.13
LT Debt / Equity
0.08
-
-
EPS (TTM)
-0.22
EPS next Y
-0.01
EPS next Q
-
EPS this Y
-0%
EPS next Y
-96.88%
EPS next 5Y
-132.99%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
16.03%
EPS Q/Q
-39.42%
-
-
-
-
SMA20
16.13%
SMA50
-16.28%
SMA100
9.09%
Inst Own
-
Inst Trans
-
ROA
-36%
ROE
-44%
ROC
-0.53%
Gross Margin
48%
Oper. Margin
-113%
Profit Margin
-99%
Payout
-
Shs Outstand
361.48M
Shs Float
324.7M
-
-
-
-
Target Price
-
52W Range
22.718-50.0
52W High
-31.5%
52W Low
+55.68%
RSI
41
Rel Volume
0.84
Avg Volume
846.74K
Volume
709.1K
Perf Week
-6.8%
Perf Month
-0.72%
Perf Quarter
-2.84%
Perf Half Y
7.03%
-
-
-
-
Beta
0.839
-
-
Volatility
0.96%, 2.58%
Prev Close
-1.44%
Price
34.25
Change
-2.31%
CREO.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0.06 | 0.15 | 0.15 | |
Net income per share | -0.11 | -0.13 | -0.13 | -0.15 | -0.15 | |
Operating cash flow per share | -0.16 | -0.09 | -0.1 | -0.16 | -0.14 | |
Free cash flow per share | -0.17 | -0.1 | -0.1 | -0.2 | -0.16 | |
Cash per share | 0.49 | 0.64 | 0.28 | 0.26 | 0.07 | |
Book value per share | 0.53 | 0.66 | 0.39 | 0.45 | 0.27 | |
Tangible book value per share | 0.52 | 0.65 | 0.1 | 0.17 | 0.01 | |
Share holders equity per share | 0.53 | 0.66 | 0.39 | 0.45 | 0.27 | |
Interest debt per share | 0 | 0 | 0.07 | 0.06 | 0.05 | |
Market cap | 179.65M | 227.58M | 312.9M | 245.01M | 45.79M | |
Enterprise value | 135.49M | 147.25M | 280.17M | 212.03M | 42.79M | |
P/E ratio | -18.2 | -14.3 | -15.4 | -9.96 | -1.7 | |
Price to sales ratio | 0 | 16.89K | 33.19 | 9.74 | 1.69 | |
POCF ratio | -12.66 | -19.72 | -19.45 | -9.43 | -1.83 | |
PFCF ratio | -11.53 | -17.98 | -18.78 | -7.63 | -1.62 | |
P/B Ratio | 3.77 | 2.75 | 4.98 | 3.34 | 0.93 | |
PTB ratio | 3.77 | 2.75 | 4.98 | 3.34 | 0.93 | |
EV to sales | 0 | 10.93K | 29.71 | 8.43 | 1.57 | |
Enterprise value over EBITDA | -11.67 | -8.01 | -12.85 | -7.74 | -1.54 | |
EV to operating cash flow | -9.54 | -12.76 | -17.42 | -8.16 | -1.71 | |
EV to free cash flow | -8.69 | -11.63 | -16.82 | -6.6 | -1.51 | |
Earnings yield | -0.05 | -0.07 | -0.06 | -0.1 | -0.59 | |
Free cash flow yield | -0.09 | -0.06 | -0.05 | -0.13 | -0.62 | |
Debt to equity | 0.01 | 0.01 | 0.17 | 0.13 | 0.18 | |
Debt to assets | 0.01 | 0.01 | 0.12 | 0.09 | 0.12 | |
Net debt to EBITDA | 3.8 | 4.37 | 1.5 | 1.2 | 0.11 | |
Current ratio | 29.58 | 17.03 | 3.3 | 3.1 | 1.93 | |
Interest coverage | -1.07K | -1.35K | -241.15 | -126.41 | -124.22 | |
Income quality | 1.44 | 0.73 | 0.79 | 1.06 | 0.93 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 1.41K | 2.92 | 1.65 | 1.62 | |
Research and developement to revenue | 0 | 604.64 | 1.08 | 0.51 | 0.5 | |
Intangibles to total assets | 0.01 | 0.01 | 0.51 | 0.46 | 0.63 | |
Capex to operating cash flow | 0.1 | 0.1 | 0.04 | 0.24 | 0.13 | |
Capex to revenue | 0 | -82.97 | -0.06 | -0.24 | -0.12 | |
Capex to depreciation | -4.19 | -1.74 | -0.36 | -2.39 | -1.05 | |
Stock based compensation to revenue | 0 | 115.4 | 0.08 | 0.1 | 0.05 | |
Graham number | 1.14 | 1.37 | 1.05 | 1.22 | 0.95 | |
ROIC | -0.21 | -0.19 | -0.27 | -0.29 | -0.45 | |
Return on tangible assets | -0.2 | -0.18 | -0.44 | -0.45 | -0.96 | |
Graham Net | 0.5 | 0.63 | 0.15 | 0.16 | 0 | |
Working capital | 46.87M | 81.04M | 41.44M | 41.43M | 16.2M | |
Tangible asset value | 47.41M | 81.8M | 16.01M | 27.5M | 2.2M | |
Net current asset value | 46.48M | 80.49M | 29.81M | 33.88M | 7.75M | |
Invested capital | 0.01 | 0.01 | 0.17 | 0.13 | 0.18 | |
Average receivables | 0 | 3.7M | 5.71M | 8.05M | 9.47M | |
Average payables | 0 | 831.17K | 1.69M | 3M | 3.91M | |
Average inventory | 0 | 514.82K | 3.77M | 7.66M | 8.91M | |
Days sales outstanding | 0 | 110.48K | 283.86 | 127.06 | 136.68 | |
Days payables outstanding | 813.43 | 518.28 | 128.38 | 80.02 | 91.02 | |
Days of inventory on hand | 332.93 | 408.17 | 355.65 | 192.34 | 198.35 | |
Receivables turnover | 0 | 0 | 1.29 | 2.87 | 2.67 | |
Payables turnover | 0.45 | 0.7 | 2.84 | 4.56 | 4.01 | |
Inventory turnover | 1.1 | 0.89 | 1.03 | 1.9 | 1.84 | |
ROE | -0.21 | -0.19 | -0.32 | -0.34 | -0.55 | |
Capex per share | -0.02 | -0.01 | 0 | -0.04 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2018-03-31 | 2018-06-30 | 2018-12-31 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0.07 | 0.06 | |
Net income per share | -0.03 | -0.05 | -0.06 | -0.07 | -0.04 | |
Operating cash flow per share | -0.02 | -0.03 | -0.07 | -0.05 | -0.06 | |
Free cash flow per share | -0.02 | -0.03 | -0.08 | -0.06 | -0.06 | |
Cash per share | 0 | 0.08 | 0.45 | 0.07 | 0.1 | |
Book value per share | 0 | 0.09 | 0.48 | 0.27 | 0.26 | |
Tangible book value per share | 0 | 0.09 | 0.48 | 0.01 | 0.09 | |
Share holders equity per share | 0 | 0.09 | 0.48 | 0.27 | 0.26 | |
Interest debt per share | 0 | 0.01 | 0 | 0.05 | 0.03 | |
Market cap | 91.73M | 100.39M | 198.18M | 45.8M | 93.27M | |
Enterprise value | 0 | 94.47M | 153.59M | 42.8M | 90.97M | |
P/E ratio | -10.91 | -5.82 | -8.91 | -0.85 | -2.01 | |
Price to sales ratio | 0 | 956.09 | 58.84K | 3.38 | 5.94 | |
POCF ratio | -52.45 | -38.52 | -28.61 | -4.99 | -6.26 | |
PFCF ratio | -46.79 | -37.31 | -26.2 | -4.36 | -6.06 | |
P/B Ratio | 0 | 13.7 | 4.15 | 0.93 | 1.35 | |
PTB ratio | 0 | 13.7 | 4.15 | 0.93 | 1.35 | |
EV to sales | 0 | 899.74 | 45.6K | 3.16 | 5.79 | |
Enterprise value over EBITDA | 0 | -18.9 | -23.81 | -3.25 | -7.78 | |
EV to operating cash flow | 0 | -36.25 | -22.17 | -4.67 | -6.11 | |
EV to free cash flow | 0 | -35.11 | -20.3 | -4.07 | -5.91 | |
Earnings yield | -0.02 | -0.04 | -0.03 | -0.29 | -0.12 | |
Free cash flow yield | -0.02 | -0.03 | -0.04 | -0.23 | -0.17 | |
Debt to equity | 0 | 0.06 | 0.01 | 0.18 | 0.13 | |
Debt to assets | 0 | 0.05 | 0.01 | 0.12 | 0.1 | |
Net debt to EBITDA | 0 | 1.18 | 6.91 | 0.23 | 0.2 | |
Current ratio | 0 | 4.65 | 29.58 | 1.93 | 4.13 | |
Interest coverage | -1.35K | -2.72K | -1.88K | -71.38 | -134 | |
Income quality | 0.83 | 0.6 | 1.25 | 0.68 | 1.28 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | -0.02 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 50.46 | 1.98K | 1.58 | 1.33 | |
Research and developement to revenue | 0 | 21.9 | 870.12 | 0.45 | 0 | |
Intangibles to total assets | 0 | 0 | 0.01 | 0.63 | 0.51 | |
Capex to operating cash flow | 0.12 | 0.03 | 0.09 | 0.15 | 0.03 | |
Capex to revenue | 0 | -0.81 | -189.26 | -0.1 | -0.03 | |
Capex to depreciation | -2.73 | -0.47 | -4.32 | -0.81 | -0.29 | |
Stock based compensation to revenue | 0 | 4.86 | 205.81 | 0.05 | 0.04 | |
Graham number | 0 | 0.33 | 0.77 | 0.68 | 0.5 | |
ROIC | 0 | -0.78 | -0.16 | -0.23 | -0.15 | |
Return on tangible assets | 0 | -0.45 | -0.11 | -0.48 | -0.27 | |
Graham Net | 0 | 0.06 | 0.43 | 0 | 0.08 | |
Working capital | 0 | 6.87M | 46.87M | 16.2M | 37.2M | |
Tangible asset value | 0 | 7.32M | 47.41M | 2.2M | 23.7M | |
Net current asset value | 0 | 6.46M | 46.48M | 7.75M | 29.4M | |
Invested capital | 0 | 0.06 | 0.01 | 0.18 | 0.13 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 558.05 | 0 | 67.67 | 83.69 | |
Days payables outstanding | 0 | 0 | 31.22K | 93.88 | 68.18 | |
Days of inventory on hand | 0 | 0 | 12.78K | 97.27 | 72.73 | |
Receivables turnover | 0 | 0.16 | 0 | 1.33 | 1.08 | |
Payables turnover | 0 | 0 | 0 | 0.96 | 1.32 | |
Inventory turnover | 0 | 0 | 0.01 | 0.93 | 1.24 | |
ROE | 0 | -0.59 | -0.12 | -0.27 | -0.17 | |
Capex per share | 0 | 0 | -0.01 | -0.01 | 0 |
CREO.L Frequently Asked Questions
What is Creo Medical Limited stock symbol ?
Creo Medical Limited is a GB stock and trading under the symbol CREO.L
What is Creo Medical Limited stock quote today ?
Creo Medical Limited stock price is $34.25 today.
Is Creo Medical Limited stock public?
Yes, Creo Medical Limited is a publicly traded company.